Hippo Holdings Inc. (HIPO) Key Metrics
HIPO valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $931.0M
- Enterprise value
- $590.2M
- P/E (TTM)
- 7.6
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 1.8 10-yr median 1.8
- Price / book
- 1.7 10-yr median 1.3
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.55
HIPO key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsHIPO valuation Price multiples at each fiscal year-end price.
HIPO returns How much profit the business earns on the capital it uses.
HIPO per-share figures Results divided by the shares outstanding at year-end.
HIPO financial health Debt, liquidity and how easily interest is covered.
HIPO efficiency & capital use Working capital cycle and where the cash goes.
HIPO valuation history
HIPO returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HIPO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HIPO cash returned to shareholders
HIPO price vs earnings per share
HIPO key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $782.4M | $661.2M | $215.0M | $309.4M | $1.09B | — | — |
| Enterprise value | $362.8M | $473.6M | −$261.1M | −$302.1M | $310.2M | — | — |
| P/E ratio | 13.6 | — | — | — | — | — | — |
| Price / sales | 1.7 | 1.8 | 1.0 | 2.6 | 12.0 | — | — |
| Price / book | 1.8 | 1.8 | 0.6 | 0.5 | 1.3 | — | — |
| Price / free cash flow | 86.0 | 14.0 | — | — | — | — | — |
| Price / operating cash flow | 85.0 | 13.9 | — | — | — | — | — |
| EV / sales | 0.8 | 1.3 | -1.2 | -2.5 | 3.4 | — | — |
| EV / EBITDA | 4.3 | — | — | — | — | — | — |
| EV / free cash flow | 39.9 | 10.0 | — | — | — | — | — |
| Earnings yield | 7.4% | −6.1% | −127.0% | −107.8% | −33.9% | — | — |
| Free cash flow yield | 1.2% | 7.1% | −64.7% | −58.6% | −13.0% | — | — |
| Shareholder yield (dividends + buybacks) | 1.9% | 2.4% | 0.8% | 1.3% | 0.0% | — | — |
| Share price at fiscal year-end | $30.08 | $26.77 | $9.12 | $13.60 | $70.75 | — | — |
| Per share | |||||||
| Revenue per share | $18.02 | $15.06 | $8.89 | $5.26 | $5.89 | — | — |
| Earnings per share | $2.22 | −$1.64 | −$11.58 | −$14.66 | −$24.00 | — | — |
| Operating cash flow per share | $0.35 | $1.92 | −$3.92 | −$7.10 | −$8.05 | — | — |
| Free cash flow per share | $0.35 | $1.91 | −$5.90 | −$7.97 | −$9.17 | — | — |
| Cash per share | $18.15 | $8.00 | $20.82 | $28.15 | $50.71 | — | — |
| Book value per share | $16.77 | $14.66 | $16.03 | $25.93 | $55.55 | — | — |
| Tangible book value per share | $11.30 | $12.02 | $12.82 | $23.04 | $48.34 | — | — |
| Capex per share | $0.00 | $0.01 | $1.98 | $0.87 | $1.12 | — | — |
| Debt per share | $2.01 | $0.40 | $0.63 | $1.27 | — | — | — |
| Shares outstanding | 26.0M | 24.7M | 23.6M | 22.7M | 15.5M | — | — |
| Change in shares outstanding | +5.3% | +4.8% | +3.7% | +47.0% | — | — | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | 14.5% | −10.9% | −56.4% | −46.0% | −112.5% | — | −70.0% |
| Return on invested capital (ROIC) | 65.5% | −56.7% | — | — | — | — | −59.5% |
| Return on assets (ROA) | 3.3% | −2.6% | −17.7% | −20.8% | −28.3% | −24.6% | −48.7% |
| Return on tangible assets | 3.3% | −2.7% | −18.8% | −22.2% | −24.3% | −16.0% | −57.2% |
| Free cash flow margin | 1.9% | 12.7% | −66.3% | −151.4% | −155.6% | −145.0% | −86.5% |
| Income quality (OCF / net income) | 0.16 | — | — | — | — | — | — |
| Financial health | |||||||
| Total debt | $52.4M | $10.0M | $14.8M | $28.9M | — | $273.0M | — |
| Cash & short-term investments | $472.0M | $197.6M | $490.9M | $640.4M | $784.7M | $452.3M | $23.3M |
| Net debt | −$419.6M | −$187.6M | −$476.1M | −$611.5M | −$784.7M | −$179.3M | −$23.3M |
| Debt / equity | 0.12 | 0.03 | 0.04 | 0.05 | — | — | — |
| Debt / assets | 0.03 | 0.01 | 0.01 | 0.02 | — | 0.28 | — |
| Net debt / EBITDA | −5.01 | — | — | — | — | — | −8.03 |
| Current ratio | 1.15 | 1.36 | 1.31 | 1.61 | 6.30 | 6.72 | 1.28 |
| Quick ratio | 1.15 | 1.36 | 2.16 | 2.42 | 11.42 | 6.73 | 1.28 |
| Interest coverage | — | — | — | -130.1 | -1.8 | -5.5 | — |
| Working capital | $208.4M | $96.7M | $328.2M | $554.3M | $967.1M | $548.8M | $5.1M |
| Invested capital | $16.5M | $174.5M | −$98.2M | −$21.6M | $74.9M | −$378.9M | $95.4M |
| Tangible asset value | $293.9M | $300.1M | $309.0M | $527.8M | $750.1M | −$295.9M | $127.0M |
| Net current asset value | $90.1M | −$813.6M | $256.7M | $490.6M | $368.7M | −$534.1M | $5.1M |
| Graham number | $28.93 | — | — | — | — | — | — |
| Graham net-net per share | −$18.27 | −$34.63 | −$30.67 | −$16.25 | −$12.33 | — | — |
| Capital allocation | |||||||
| Share buybacks (net) | $14.5M | $15.6M | $1.8M | $3.9M | $0 | — | — |
| Dividends + buybacks / free cash flow | 159.3% | 33.1% | — | — | — | — | — |
| Capex / revenue | 0.0% | 0.1% | 22.3% | 16.5% | 19.1% | 18.2% | 2.6% |
| Capex / operating cash flow | 1.1% | 0.6% | — | — | — | — | — |
| Capex / depreciation | 0.00 | 0.01 | 2.36 | 1.30 | 1.58 | 1.40 | 0.31 |
| Stock-based compensation / revenue | 6.3% | 10.3% | 27.4% | 51.7% | 26.6% | 33.3% | 63.1% |
| R&D / revenue | — | 8.3% | 22.4% | 48.0% | 39.7% | — | — |
| SG&A / revenue | 21.5% | 19.0% | 38.0% | 144.8% | 166.0% | 211.6% | 306.9% |
| Efficiency | |||||||
| Days sales outstanding | 336.2 | 330.0 | 830.4 | 1,240.0 | 1,115.6 | 693.2 | 36.8 |
| Days of inventory on hand | — | — | -1,026.6 | -1,710.0 | -1,616.6 | -17.7 | — |
| Days payables outstanding | 466.1 | 339.7 | 324.5 | 425.3 | 480.1 | 517.3 | — |
| Cash conversion cycle (days) | -129.9 | -9.7 | -520.7 | -895.3 | -981.2 | 158.3 | — |
| Receivables turnover | 1.09 | 1.11 | 0.44 | 0.29 | 0.33 | 0.53 | 9.91 |
| Payables turnover | 0.78 | 1.07 | 1.12 | 0.86 | 0.76 | 0.71 | 0.00 |
| Asset turnover | 0.27 | 0.24 | 0.14 | 0.07 | 0.07 | 0.09 | 0.20 |
| Average receivables | $431.6M | $336.4M | $477.1M | $406.6M | $278.8M | $98.0M | $3.5M |
| Average payables | $293.6M | $277.1M | $260.6M | $208.7M | $139.3M | $49.6M | $3.2M |
| Average inventory | — | — | −$824.4M | −$839.0M | −$469.0M | −$1.7M | — |
| Intangibles / total assets | 7.5% | 4.2% | 5.0% | 4.2% | 6.8% | 9.8% | 14.8% |
Computed from HIPO's annual financial statements (latest annual report filed March 5, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HIPO valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Hippo traded at 13.6 times earnings. Based on the latest twelve months, the trailing P/E is 7.6. Hippo earned a return on equity of 14.5% and a return on invested capital of 65.5% in fiscal 2025. It ended the year with $52.4 million of debt and $472.0 million in cash and short-term investments, a net cash position of $419.6 million. It returned $14.5 million to shareholders: $0 in dividends and $14.5 million in share buybacks, 159% of free cash flow.
See the HIPO income statement, the HIPO chart for price history, or the HIPO stock overview for the latest quote and news.
HIPO key metrics FAQ
What is Hippo's P/E ratio?
Hippo's trailing P/E ratio is 7.6 based on the last twelve months of earnings (as of October 18, 2026). At the end of fiscal 2025 it was 13.6.
What is Hippo's EV/EBITDA?
Hippo's enterprise value was 4.3 times EBITDA at the end of fiscal 2025 (enterprise value $362.8 million, EBITDA $83.7 million).
What is Hippo's return on equity?
Hippo's return on equity (ROE) was 14.5% in fiscal 2025: net income of $57.7 million on average shareholders' equity of $399.1 million.
What is Hippo's ROIC?
Hippo's return on invested capital was 65.5% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Hippo have?
Hippo had total debt of $52.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.12 and more cash than debt.
Does Hippo buy back its shares?
Yes. Hippo spent $14.5 million on net share repurchases in fiscal 2025 Shares outstanding changed +5.3% over the year, to 26.0M..
What is Hippo's free cash flow yield?
Hippo generated $9.1 million of free cash flow in fiscal 2025, a free cash flow yield of 1.2% on its market value at year-end ($782.4 million).
What is Hippo's current ratio?
Hippo's current ratio was 1.15 at the end of fiscal 2025: current assets were 1.15 times current liabilities.